Adriana Albini

I am writing a note in tribute to one of our oncology research leaders, who has just left us: Giorgio Parmiani – a pioneer in immunology. The scientific community mourns him. Parmiani was internationally recognised in the field of tumour…

There was a time when all that oncologists treating solid tumours needed to know about leukocytes was how to measure the damage that cytotoxic drugs inflicted on their patients’ white blood cell count and their capacity to fight off infections.…

Gordon McVie passed away on January 20th after a lifetime of pioneering contributions to the cause of defeating cancer: as clinician, researcher, manager, advocate and educator. He was a formidable presence on the UK and European stage, driven by a…

Vitamin D has drawn much scientific interest and media coverage in recent years, and increasingly so in 2020, when a link was found between vitamin D deficiency and Covid-19. This is a very unusual vitamin, in that it behaves both…

Editor Adriana Albini talks readers through the stories we’ve selected for our Winter print issue. They cover a wide range of topics, but are really interested only in one thing: how do we improve the quality of care we tailor…

With the 2020 Nobel Prize going to three scientists who led on the discovery of the hepatitis C virus, Adriana Albini acknowledges the valuable contributions that these and other virologists have made over many decades to advancing our understanding of…

‘Tackling cancer in interesting times’ was the theme of my first Editorial for Cancer World. I wrote that at the start of February this year, at a time when Europe remained largely oblivious to the implications of a new virus…